Is DIAGENODE S.A. still active?

Yes, DIAGENODE S.A. is currently active.

Where is DIAGENODE S.A. registered?

DIAGENODE S.A.'s registered address is Rue du Bois St-Jean 3, 4102 Seraing, Belgium.

How many employees does DIAGENODE S.A. have?

Based on its most recently filed annual accounts (fiscal year ending 30 Sep 2025), DIAGENODE S.A. reported 100.5 full-time equivalent employees.

What is DIAGENODE S.A.'s annual turnover?

DIAGENODE S.A.'s most recently filed annual turnover (fiscal year ending 30 Sep 2025) was €11,857,386.

Did DIAGENODE S.A. make a profit or a loss?

DIAGENODE S.A.'s most recently filed annual accounts (fiscal year ending 30 Sep 2025) reported a loss of €2,953,930.

When did DIAGENODE S.A. last file annual accounts?

DIAGENODE S.A.'s most recently filed annual accounts cover the fiscal year ending 30 Sep 2025.

Is DIAGENODE S.A. B Corp certified?

We have no B Corp certification on file for DIAGENODE S.A..

Does DIAGENODE S.A. hold Fairtrade certification?

No, DIAGENODE S.A. does not currently hold Fairtrade certification.

DIAGENODE S.A.

Q: What is DIAGENODE S.A.'s legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

Q: When was DIAGENODE S.A. founded?

DIAGENODE S.A. was founded on 30 May 2003, making it 23 years old.

Q: What does DIAGENODE S.A. do?

DIAGENODE S.A.'s registered main activities are Research and experimental development on biotechnology, Manufacture of irradiation, electromedical and electrotherapeutic equipment, Manufacture of composite diagnostic or laboratory reagents, and Manufacture of other pharmaceutical products.

BE 0480.422.786

Copied!

NV/SA

Status

Active

Founded

30 May 2003 · 23 yrs

Size

Medium · 100.5 FTE

Legal name

DIAGENODE

Main activity

Research and experimental development on biotechnology

Website

diagenode.com

Activities

4 activities

Research and experimental development on biotechnologyManufacture of irradiation, electromedical and electrotherapeutic equipmentManufacture of composite diagnostic or laboratory reagentsManufacture of other pharmaceutical products

Financials

Turnover2025

€11.9M-9.1%

Profit / Loss2025

−€3M<-1000%

Equity2025

€8.7M-27.6%

2025	2024	2023
€11,857,386-9.1%	€13,050,694-2.2%	€13,344,219
-€2,953,930<-1000%	€90,613-94.2%	€1,553,486
€8,701,475-27.6%	€12,018,173-3.1%	€12,402,213
€12,262,608+19.4%	€10,266,629-45.4%	€18,816,109
€1,213,035-41%	€2,054,654-5.2%	€2,168,395
100.5-0.3%	100.8-4%	105
€117,984-8.9%	€129,471+1.9%	€127,088

Frequently asked questions

01What is DIAGENODE S.A.'s official registered name?

DIAGENODE.

02What is DIAGENODE S.A.'s enterprise number (VAT number)?

BE 0480.422.786.

03What is DIAGENODE S.A.'s legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

04When was DIAGENODE S.A. founded?

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

	2025	2024	2023
Income statement
	€11,857,386-9.1%	€13,050,694-2.2%	€13,344,219
	€9,896,910+4.9%	€9,436,618-1.2%	€9,553,703
	-€2,511,760-950.6%	€295,278-82.4%	€1,677,043
	-€201,285-107.9%	€2,544,348-36.5%	€4,005,470
	-€581,805-128.6%	€2,033,283-51.4%	€4,188,313
	-€2,953,930<-1000%	€90,613-94.2%	€1,553,486
	€83,889+73.2%	€48,438-18.6%	€59,490
Profitability
	-1.7%-108.7%	19.5%-35%	30.0%
	-24.9%<-1000%	0.7%-94%	11.6%
	-33.9%<-1000%	0.8%-94%	12.5%
	-14.0%<-1000%	0.4%-91.7%	4.9%
Solvency
	€21,058,962-5.7%	€22,342,633-29.3%	€31,608,936
	€7,708,819-9.9%	€8,560,340-7.5%	€9,252,491
	€4,629-86.7%	€34,725-85.7%	€243,450
	€8,701,475-27.6%	€12,018,173-3.1%	€12,402,213
	41.3%-23.2%	53.8%+37.1%	39.2%
	€3,368,684-16.3%	€4,026,715-13.8%	€4,670,323
	0.39+15.6%	0.34-11%	0.38
	€12,262,608+19.4%	€10,266,629-45.4%	€18,816,109
	1.41+65%	0.85-43.7%	1.52
	-12.87<-1000%	0.76-84%	4.78
Liquidity
	€1,213,035-41%	€2,054,654-5.2%	€2,168,395
	€4,208,140-11.6%	€4,759,677+28.6%	€3,702,430
	€6,050,536+27.4%	€4,750,160-62%	€12,509,472
	€2,062,042-14.6%	€2,414,786-23.4%	€3,151,234
	€8,571,414+45.5%	€5,889,632-58%	€14,013,099
	1.29-23.7%	1.69+31.8%	1.28
	€3,760,767-40.7%	€6,343,058+3.4%	€6,133,588
Efficiency
	186 days+40.2%	133 days-61.2%	342 days
	69 days-10.6%	77 days-28.3%	108 days
	238 days-2.4%	244 days+6.9%	229 days
	1.44-14.3%	1.68	—
Profit appropriation
	€487,9690%	€487,969+0.9%	€483,439
	-€155,608-105.6%	€2,798,322+3.2%	€2,712,239